Welcome to our dedicated page for CANSORTIUM news (Ticker: CNTMF), a resource for investors and traders seeking the latest updates and insights on CANSORTIUM stock.
Cansortium Inc (CNTMF) is a leading multi-state operator in the cannabis sector, focusing on cultivation, processing, and dispensing high-quality medical and recreational cannabis products. With a strong presence in key markets like Florida, New York, and Pennsylvania, Cansortium is dedicated to providing patients and consumers with innovative and effective cannabis solutions. The company's robust financial position, strategic partnerships, and commitment to compliance and sustainability set it apart in the industry.
News
Rhea-AI Summary
Cansortium Inc., a multi-state cannabis company operating under the FLUENT brand, will hold a conference call to discuss its Q3 2023 financial and operating results. The call will take place on November 13, 2023, at 4:30 p.m. Eastern time. Interested parties can submit questions prior to the call. Dial-in numbers and conference ID are provided.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-19.05%
Tags
-
Rhea-AI Summary
Cansortium Inc. reports Q2 revenue of $24.4 million, up 9% sequentially and YoY. Q2 cash from operations is $4.8 million, marking the 7th consecutive quarter of positive cash flow. CEO expects to open 1-2 new stores in Florida by year end. Adjusted gross profit increased 5% to $15.8 million. Cash and cash equivalents are approximately $8.8 million with total debt of $59.3 million. The company completed its headquarters relocation to Tampa and plans to open a brick-and-mortar delivery center in Houston. Conference call scheduled for today at 4:30 p.m. Eastern time.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Cansortium Inc. announces positive voting results from annual general and special meeting of shareholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.62%
Tags
News
Rhea-AI Summary
FLUENT opens its 33rd medical cannabis dispensary in Florida and 36th retail location nationwide in Jacksonville, expanding access for westside residents. The new 3,600 square foot dispensary offers promotional discounts of 50% off during the Grand Opening week. Patients will have access to a wide range of products and convenient services like in-store express stations and a drive-thru.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Cansortium Inc. to hold conference call on August 28, 2023 to discuss Q2 financial and operating results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.8%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.12%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.11%
Tags
-
Rhea-AI Summary
Cansortium Inc., a cannabis company operating under the FLUENT brand, issued a statement on the two failed cannabis bills in Texas. The company expressed disappointment but commended lawmakers for their efforts. They are expanding their delivery capabilities in Houston and Austin and remain committed to broadening access to medical cannabis in Texas.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.27%
Tags
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.19%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.63%
Tags
FAQ
What is the current stock price of CANSORTIUM (CNTMF)?
The current stock price of CANSORTIUM (CNTMF) is $0.0841 as of November 22, 2024.
What is the market cap of CANSORTIUM (CNTMF)?
The market cap of CANSORTIUM (CNTMF) is approximately 24.3M.
What is Cansortium Inc's primary focus?
Cansortium Inc is primarily focused on cultivation, processing, and dispensing high-quality medical and recreational cannabis products.
In which key markets does Cansortium operate?
Cansortium has a strong presence in key markets such as Florida, New York, and Pennsylvania.
What sets Cansortium apart in the cannabis industry?
Cansortium is known for its robust financial position, strategic partnerships, and commitment to compliance and sustainability.
How can investors get in touch with Cansortium's CEO?
Investors can contact Robert Beasley, CEO of Cansortium Inc, at (850) 972-8077.
Where can investors find more information about Cansortium Inc?
For more information about Cansortium Inc, visit investors.getFLUENT.com.
What is Cansortium's outstanding debt composition?
Cansortium's outstanding debt consists of a US$66 million senior secured term loan, a US$3.1 million convertible debenture, and US$0.4 million of combined auto, equipment, and insurance financing or loans.
What is the cash position net of debt for Cansortium Inc?
The cash position net of debt is equal to the cash balance of RIV Capital as of March 31, 2024, plus the cash balance of Cansortium as of March 31, 2024, less Cansortium’s outstanding debt of US$69 million as of March 31, 2024.
How does Cansortium calculate adjusted gross profit?
Cansortium calculates adjusted gross profit from gross profit plus (minus) the changes in fair value of biological assets.
What drives Cansortium's success in the cannabis industry?
Cansortium's success is attributed to its innovative products, strategic market presence, and customer-focused approach.
What is the vision of Cansortium Inc for the future?
Cansortium aims to expand its operations, strengthen its market position, and continue providing top-quality cannabis products to consumers.
CANSORTIUM INC
OTC:CNTMF
CNTMF Rankings
CNTMF Stock Data
24.26M
178.07M
34.66%
0.43%
Drug Manufacturers - Specialty & Generic
Healthcare
United States of America
Tampa